Developing as a promising development in the battle against obesity, the drug is attracting considerable interest . It combines properties of two known GLP-1 binding agonists, dulaglutide , and an additional glucose-dependent hormonal component. Early clinical findings have shown impressive weight reduction in individuals with a high BMI , perh… Read More